title: Anti-GP2 IgA: a biomarker for disease severity and/or cholangiocarcinoma in primary sclerosing cholangitis?
authors: Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
authors: Sumera
authors: S
authors: Rizvi
authors: Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
authors: Ju Dong
authors: JD
authors: Yang
authors: Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
authors: Gregory J
authors: GJ
authors: Gores
mesh_terms: D001650:Bile Duct Neoplasms; D001653:Bile Ducts, Intrahepatic; D015415:Biomarkers; D018281:Cholangiocarcinoma; D015209:Cholangitis, Sclerosing; D006801:Humans; D007070:Immunoglobulin A
chemical_list: D015415:Biomarkers; D007070:Immunoglobulin A
keywords: CHOLANGIOCARCINOMA; PRIMARY SCLEROSING CHOLANGITIS